Brief: CellaVision Q2 EBITDA Down At SEK 36.2 Mln

CellaVision AB

16/07/2020 07:25

July 16 (Reuters) - CellaVision AB  CEVI.ST :
    * REG-CELLAVISION AB: GOOD PROFITABILITY DESPITE NEGATIVE
COVID-19-EFFECT
    * Q2 NET SALES SEK 118.0 MILLION VERSUS SEK 112.4 MILLION
YEAR AGO
    * EXPECTS COVID-19 PANDEMIC TO HAVE A SIGNIFICANT NEGATIVE
IMPACT
ON CELLAVISION'S SALES AND EARNINGS FOR A NUMBER OF MONTHS TO
COME
    * Q2 EBITDA AMOUNTED TO SEK 36.2 MILLION (41.3)

Source text for Eikon:  ID:nGNEbqjdD3 
Further company coverage:  CEVI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))